In this solo episode, I'm breaking down one of the most frequently misunderstood aspects of hormone replacement therapy: how to actually know whether your dose is right. Not just "right enough to take the edge off," but right for you — your biology, your labs, your symptoms, your history, and your long-term health goals.

We cover all three hormones: estradiol, progesterone, and testosterone. We look at what the research tells us, where the evidence is strong, where it's still evolving, and why the old-school instruction to simply use the lowest possible dose until your symptoms disappear does not reflect the full picture that modern hormone science is revealing.

And yes, I also cover the other end of the spectrum — because more is not always better, and there are real signs that you may be taking more than your body needs. HRT optimization is not about a single number on a lab report. It's about learning to read your biology as a whole.

What We Discuss in This Episode

• Why symptom relief is not the same as HRT optimization
• The limitations of the "lowest dose possible" approach for long-term health
• How estradiol dose may influence brain health, hippocampal volume, mood, bone density, metabolism, and skin
• What research suggests about estradiol and cognitive health during menopause
• The timing hypothesis: why starting HRT earlier in the menopause transition may matter
• Why there is no universally agreed-upon estradiol target for longevity
• Why progesterone blood testing can be so inconsistent and difficult to interpret
• Oral, transdermal, and vaginal progesterone: how route affects absorption and outcomes
• Common progesterone doses used for uterine protection and sleep support
• Why total testosterone is an incomplete picture — and what free testosterone actually tells you
• Androgen sensitivity: why the same testosterone dose produces very different results in different women
• Signs that you may actually be getting too much HRT
• How to evaluate labs and symptoms together for a clearer picture of your optimization

Key Takeaways

• Symptom relief alone is not a reliable indicator that your HRT dose is fully optimized for long-term health outcomes including brain, bone, and metabolic health.
• The widely repeated advice to use the "lowest dose possible" can leave some women in a protective deficit — particularly when it comes to estradiol's potential effects on bone density, hippocampal volume, mood, and metabolism.
• Research suggests estradiol may influence brain health, including hippocampal volume and cognitive function, but there is no single universally accepted target level for longevity or neuroprotection.
• The timing hypothesis proposes that when you start HRT may matter as much as which hormones you use — women who begin earlier in the menopause transition may experience different outcomes than those who start later.
• Progesterone blood testing is notoriously difficult to interpret, particularly with oral micronized progesterone. Uterine protection and sleep support depend on dose, route of administration, and individual response — not on achieving a specific serum level.
• Total testosterone alone does not tell you enough. Free testosterone and your individual sensitivity to androgens determine whether you are getting the libido, muscle, energy, and motivation benefits — and whether you're getting side effects you don't want.
• Labs and symptoms must be interpreted together. A number within the reference range on a lab report does not automatically mean your dose is right for you.

Listen to the full episode on Apple Podcasts

Common Questions About HRT Optimization

What is the optimal estradiol level for menopause?

There is no single universally accepted optimal estradiol level, which is one of the most important things to understand about HRT. Some clinicians target specific ranges based on symptom response and research associations with bone and brain health, while others focus primarily on symptom resolution and lab trends. What's considered optimal may also differ depending on whether you're in perimenopause or postmenopause, your health history, and the route of estradiol you're using (patch, gel, spray, or pellet). A functional medicine or hormone-specialized provider can help you interpret your labs in context rather than against a one-size-fits-all reference range.

How do you know if your HRT dose is too low?

Persistent symptoms are one signal — particularly if you started HRT and initially felt better but then plateaued, or if you've never felt fully well on your current regimen. These might include ongoing brain fog, mood instability, poor sleep, low energy, low libido, joint pain, vaginal dryness, or continued weight gain despite dietary effort. However, symptoms alone don't confirm an underdose; testing estradiol and free testosterone in context, and discussing your full clinical picture with your provider, is the appropriate path forward.

Does estradiol dose affect brain health and memory?

This is an area of active and evolving research. Some studies have found associations between estradiol exposure and cognitive outcomes, including measures related to hippocampal volume and memory function in menopausal women. The timing hypothesis suggests that starting HRT earlier in the menopause transition may be important. However, the research is not yet definitive enough to establish a specific estradiol level for cognitive protection, and individual results vary. Discussing brain health as a long-term goal — not just hot flash relief — with your hormone provider is a reasonable and well-grounded approach.

Why is progesterone blood testing so unreliable?

The reliability of progesterone serum testing depends heavily on route of administration. Oral micronized progesterone is substantially metabolized before it reaches systemic circulation, and the metabolites can produce misleading serum readings — sometimes appearing very high even when tissue-level progesterone is not correspondingly elevated. Transdermal and vaginal progesterone produce low serum levels that don't reflect tissue concentrations. Because of this, progesterone serum levels are generally not the best guide to dosing adequacy — clinical response, uterine monitoring (where applicable), and provider judgment are more reliable anchors.

What is the difference between total and free testosterone in women?

Total testosterone measures all testosterone in the bloodstream, including the large portion that is bound to proteins — primarily sex hormone-binding globulin (SHBG) — and is therefore not biologically active. Free testosterone is the unbound fraction that is available for the body to use. Because SHBG levels vary between women (and can rise significantly on oral estrogen), two women with identical total testosterone may have very different amounts of biologically available testosterone. Measuring free testosterone alongside total testosterone, and understanding SHBG, gives a much more accurate picture of androgen status.

Can you be on too much HRT?

Yes. While undertreating is a real concern, overdosing carries its own risks and side effects. Signs that estrogen may be too high include breast tenderness or swelling, bloating, headaches, mood changes, and heightened anxiety. Signs of excess testosterone can include acne, hair thinning at the scalp, facial hair growth, mood irritability, and an elevated hematocrit. The goal of optimization is finding the range that produces benefit without producing excess — and that range is individual, not universal.

How should labs and symptoms be interpreted together on HRT?

Neither labs nor symptoms alone are sufficient guides to HRT optimization. Lab values give you objective data, but reference ranges were not designed for hormone optimization — they reflect population averages, not individual thresholds for wellbeing. Symptoms tell you how you feel, but some symptoms overlap with non-hormonal causes. The most reliable approach is to track both over time, use them to have specific conversations with a knowledgeable provider, and adjust doses in a stepwise, monitored way. Periodic retesting after dose changes — not just once at baseline — allows for meaningful refinement.

What is the timing hypothesis for HRT?

The timing hypothesis (sometimes called the "critical window hypothesis") refers to the idea that initiating hormone replacement therapy earlier in the menopause transition — closer to the onset of perimenopause or within the first years after the final menstrual period — may produce different, and potentially greater, protective effects on the brain and cardiovascular system than initiating HRT many years after menopause. This hypothesis emerged in part from analyses of the Women's Health Initiative and subsequent observational research. Starting HRT later is not without potential benefit, but the nature and magnitude of those benefits may differ.

About the Author

Karen Martel is a Certified Hormone Specialist and Transformational Nutrition Coach who founded Karen Martel Midlife Solutions to address the gap in personalized women's hormonal healthcare. She specializes in bioidentical HRT, comprehensive hormone testing, and clinical coaching for women in perimenopause and menopause.